GGrantIndex
← Leaderboards

John S Markowitz

Medical University Of South Carolina

$4,835,254
Attributed
$6,310,293
Total exposure
7
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $677.6K · FY200522
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$6,310,293 · 7

By mechanism

R01$4,211,437 · 2
R21$2,098,856 · 5

Top collaborators

Most similar at Medical University Of South Carolina

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Research

Research focus

Clinical ResearchDrug KineticsIn VitroPharmaceutical PreparationsGenotypeResponsePharmacodynamicsSafetyPharmacotherapyDosageMetabolismPsychostimulantAttention Deficit Hyperactivity DisorderToxic EffectChildhoodChildDiagnosisOralEnzymesMethylphenidateIn VivoAdverse EffectsDrug InteractionsLead

Grant awards (21)

Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD$541,213
R01 · FY2022 · HD · contact PI
Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD$566,998
R01 · FY2021 · HD · contact PI
Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD$575,390
R01 · FY2020 · HD · contact PI
Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD$588,857
R01 · FY2019 · HD · contact PI
Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD$677,621
R01 · FY2018 · HD · contact PI
Genetic Variants of Human Carboxylesterase 1 Influence the Activation and Antivir$183,125
R21 · FY2012 · AI · contact PI
Genetic Variants of Human Carboxylesterase 1 Influence the Activation and Antivir$219,750
R21 · FY2011 · AI · contact PI
Drug Transporters and the Disposition of ADHD Therapeutic Agents$319,802
R01 · FY2010 · DA · contact PI
Drug Transporters and the Disposition of ADHD Therapeutic Agents$306,918
R01 · FY2009 · DA · contact PI
Drug Transporters and the Disposition of ADHD Therapeutic Agents$20,708
R01 · FY2009 · DA · contact PI
Drug Transporters and the Disposition of ADHD Therapeutic Agents$321,930
R01 · FY2008 · DA · contact PI
Drug Transporters and the Disposition of ADHD Therapeutic Agents$292,000
R01 · FY2007 · DA · contact PI
Pharmacokinetics and Drug Interactions with Milk Thistle$142,569
R21 · FY2007 · AT · contact PI
Pharmacokinetics and Drug Interactions with Milk Thistle$178,212
R21 · FY2006 · AT · contact PI
Pharmacokinetics and Drug Interactions with Milk Thistle$255,500
R21 · FY2005 · AT
P-Glycoprotein and Disposition of Psychostimulants$182,500
R21 · FY2005 · HD
P-Glycoprotein and Disposition of Psychostimulants$219,000
R21 · FY2004 · HD
Ginkgo biloba for ECT-induced Memory Deficits$182,500
R21 · FY2003 · AT
Ginkgo biloba for ECT-induced Memory Deficits$182,500
R21 · FY2002 · AT
Screening Herbs for Drug Interactions$176,600
R21 · FY2002 · AT
Screening Herbs for Drug Interactions$176,600
R21 · FY2001 · AT